ATTANA AB |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.081 SEK | +12.50% |
|
+8.00% | -18.18% |
| Apr. 30 | BioInvent Announces Evaluating Attana Technology | CI |
| Apr. 25 | Attana AB Enters Third Year of A Five-Year Service and Support Contract with A Leading Health Institute in the US | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
Attana AB is a Sweden-based biotechnology company specializing in in vitro characterization of molecular interactions mimicking in vivo conditions. The Company develops proprietary label-free biosensors, based on the Quartz Crystal Microbalance (QCM) technology, for biochemical, crude, sera and cell-based assays. Its products and research services are used by pharmaceutical and biotechnology companies to quality control the production line of a biological pharmaceutical or gain insight into advanced dynamic features of target molecules, as well as by academic institutions within the life sciences. Attanaâs biosensors are used to determine specificity, kinetics and affinity, among other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -18.18% | 2.56M | |
| -29.76% | 924M | |
| -19.12% | 130M | |
| -7.98% | 68.37M | |
| +6.78% | 60.11M | |
| +1.80% | 52.22M |
- Stock Market
- Equities
- ATANA Stock
- News Attana AB
- Attana Lands Order for Kinetic Interaction Analysis of Tissue in US
